Systematic tracking of dysregulated modules identifies novel genes in cancer
Open Access
- 14 May 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 29 (12) , 1553-1561
Abstract
Motivation: Deciphering the modus operandi of dysregulated cellular mechanisms in cancer is critical to implicate novel cancer genes and develop effective anti-cancer therapies. Fundamental to this is meticulous tracking of the behavior of core modules, including complexes and pathways across specific conditions in cancer.Keywords
This publication has 38 references indexed in Scilit:
- Pancreatic cancer genomes reveal aberrations in axon guidance pathway genesNature, 2012
- Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancerNature Genetics, 2012
- Discovery of multi-dimensional modules by integrative analysis of cancer genomic dataNucleic Acids Research, 2012
- Dissecting the expression of EEF1A1/2 genes in human prostate cancer cells: the potential of EEF1A2 as a hallmark for prostate transformation and progressionBritish Journal of Cancer, 2011
- The BioGRID Interaction Database: 2011 updateNucleic Acids Research, 2010
- The landscape of somatic copy-number alteration across human cancersNature, 2010
- Complex discovery from weighted PPI networksBioinformatics, 2009
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic AnalysesScience, 2008
- ENDEAVOUR update: a web resource for gene prioritization in multiple speciesNucleic Acids Research, 2008
- The COSMIC (Catalogue of Somatic Mutations in Cancer) database and websiteBritish Journal of Cancer, 2004